Cargando…
Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism
An association between lower bone mineral density (BMD) and presence of vascular calcification (VC) has been reported in several studies. Chronic kidney disease (CKD) causes detrimental disturbances in the mineral balance, bone turnover, and development of severe VC. Our group has previously demonst...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988613/ https://www.ncbi.nlm.nih.gov/pubmed/33301619 http://dx.doi.org/10.1002/jbmr.4203 |
_version_ | 1783668818235621376 |
---|---|
author | Mace, Maria L Gravesen, Eva Nordholm, Anders Egstrand, Soeren Morevati, Marya Nielsen, Carsten Kjaer, Andreas Behets, Geert D'Haese, Patrick Olgaard, Klaus Lewin, Ewa |
author_facet | Mace, Maria L Gravesen, Eva Nordholm, Anders Egstrand, Soeren Morevati, Marya Nielsen, Carsten Kjaer, Andreas Behets, Geert D'Haese, Patrick Olgaard, Klaus Lewin, Ewa |
author_sort | Mace, Maria L |
collection | PubMed |
description | An association between lower bone mineral density (BMD) and presence of vascular calcification (VC) has been reported in several studies. Chronic kidney disease (CKD) causes detrimental disturbances in the mineral balance, bone turnover, and development of severe VC. Our group has previously demonstrated expression of Wnt inhibitors in calcified arteries of CKD rats. Therefore, we hypothesized that the CKD‐induced VC via this pathway signals to bone and induces bone loss. To address this novel hypothesis, we developed a new animal model using isogenic aorta transplantation (ATx). Severely calcified aortas from uremic rats were transplanted into healthy rats (uremic ATx). Transplantation of normal aortas into healthy rats (normal ATx) and age‐matched rats (control) served as control groups. Trabecular tissue mineral density, as measured by μCT, was significantly lower in uremic ATx rats compared with both control groups. Uremic ATx rats showed a significant upregulation of the mineralization inhibitors osteopontin and progressive ankylosis protein homolog in bone. In addition, we found significant changes in bone mRNA levels of several genes related to extracellular matrix, bone turnover, and Wnt signaling in uremic ATx rats, with no difference between normal ATx and control. The bone histomorphometry analysis showed significant lower osteoid area in uremic ATx compared with normal ATx along with a trend toward fewer osteoblasts as well as more osteoclasts in the erosion lacunae. Uremic ATx and normal ATx had similar trabecular number and thickness. The bone formation rate did not differ between the three groups. Plasma biochemistry, including sclerostin, kidney, and mineral parameters, were similar between all three groups. ex vivo cultures of aorta from uremic rats showed high secretion of the Wnt inhibitor sclerostin. In conclusion, the presence of VC lowers BMD, impairs bone metabolism, and affects several pathways in bone. The present results prove the existence of a vasculature to bone tissue cross‐talk. © 2020 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). |
format | Online Article Text |
id | pubmed-7988613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79886132021-03-29 Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism Mace, Maria L Gravesen, Eva Nordholm, Anders Egstrand, Soeren Morevati, Marya Nielsen, Carsten Kjaer, Andreas Behets, Geert D'Haese, Patrick Olgaard, Klaus Lewin, Ewa J Bone Miner Res Original Articles An association between lower bone mineral density (BMD) and presence of vascular calcification (VC) has been reported in several studies. Chronic kidney disease (CKD) causes detrimental disturbances in the mineral balance, bone turnover, and development of severe VC. Our group has previously demonstrated expression of Wnt inhibitors in calcified arteries of CKD rats. Therefore, we hypothesized that the CKD‐induced VC via this pathway signals to bone and induces bone loss. To address this novel hypothesis, we developed a new animal model using isogenic aorta transplantation (ATx). Severely calcified aortas from uremic rats were transplanted into healthy rats (uremic ATx). Transplantation of normal aortas into healthy rats (normal ATx) and age‐matched rats (control) served as control groups. Trabecular tissue mineral density, as measured by μCT, was significantly lower in uremic ATx rats compared with both control groups. Uremic ATx rats showed a significant upregulation of the mineralization inhibitors osteopontin and progressive ankylosis protein homolog in bone. In addition, we found significant changes in bone mRNA levels of several genes related to extracellular matrix, bone turnover, and Wnt signaling in uremic ATx rats, with no difference between normal ATx and control. The bone histomorphometry analysis showed significant lower osteoid area in uremic ATx compared with normal ATx along with a trend toward fewer osteoblasts as well as more osteoclasts in the erosion lacunae. Uremic ATx and normal ATx had similar trabecular number and thickness. The bone formation rate did not differ between the three groups. Plasma biochemistry, including sclerostin, kidney, and mineral parameters, were similar between all three groups. ex vivo cultures of aorta from uremic rats showed high secretion of the Wnt inhibitor sclerostin. In conclusion, the presence of VC lowers BMD, impairs bone metabolism, and affects several pathways in bone. The present results prove the existence of a vasculature to bone tissue cross‐talk. © 2020 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). John Wiley & Sons, Inc. 2020-12-10 2021-03 /pmc/articles/PMC7988613/ /pubmed/33301619 http://dx.doi.org/10.1002/jbmr.4203 Text en © 2020 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Mace, Maria L Gravesen, Eva Nordholm, Anders Egstrand, Soeren Morevati, Marya Nielsen, Carsten Kjaer, Andreas Behets, Geert D'Haese, Patrick Olgaard, Klaus Lewin, Ewa Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism |
title | Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism |
title_full | Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism |
title_fullStr | Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism |
title_full_unstemmed | Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism |
title_short | Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism |
title_sort | chronic kidney disease–induced vascular calcification impairs bone metabolism |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988613/ https://www.ncbi.nlm.nih.gov/pubmed/33301619 http://dx.doi.org/10.1002/jbmr.4203 |
work_keys_str_mv | AT macemarial chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism AT graveseneva chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism AT nordholmanders chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism AT egstrandsoeren chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism AT morevatimarya chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism AT nielsencarsten chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism AT kjaerandreas chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism AT behetsgeert chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism AT dhaesepatrick chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism AT olgaardklaus chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism AT lewinewa chronickidneydiseaseinducedvascularcalcificationimpairsbonemetabolism |